+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Genetic Technologies Ltd (GTG) - Product Pipeline Analysis, 2020 Update

  • ID: 5240163
  • Company Profile
  • January 2021
  • 34 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • AusBiotech Ltd
  • Pharmaxis Ltd
  • Sonic Healthcare Ltd
  • MORE
Genetic Technologies Ltd (GTG) is a molecular diagnostic company that offers testing products and services to assess sporadic breast cancer risk and colorectal cancer risk assessment. It delivers the offerings by GeneType for breast cancer tests and GeneType test for colorectal cancer. GeneType for breast cancer, a test that examines woman’s clinical risk factors with scientifically validated genetic biomarkers, to enable personalized breast cancer risk assessment and GeneType for Colorectal Cancer combines patient age, genetic markers and family history to provide a more accurate assessment of colorectal cancer risk. The company serves healthcare providers and patients in the US and Australia. GTG is headquartered in Fitzroy, Victoria, Australia.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Genetic Technologies Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AusBiotech Ltd
  • Pharmaxis Ltd
  • Sonic Healthcare Ltd
  • MORE
Genetic Technologies Ltd Company Overview
  • Genetic Technologies Ltd Company Snapshot
  • Genetic Technologies Ltd Pipeline Products and Ongoing Clinical Trials Overview
  • Genetic Technologies Ltd - Pipeline Analysis Overview
  • Business Description
  • Genetic Technologies Ltd - Key Facts
  • Genetic Technologies Ltd - Major Products and Services
  • Genetic Technologies Ltd Pipeline Products by Development Stage
Genetic Technologies Ltd Pipeline Products Overview
  • Genetic Test - Breast Cancer
  • Genetic Test - Breast Cancer Product Overview
  • Genetic Test - Cardiovascular Disease
  • Genetic Test - Cardiovascular Disease Product Overview
  • Genetic Test - Colorectal Cancer
  • Genetic Test - Colorectal Cancer Product Overview
  • Genetic Test - Melanoma
  • Genetic Test - Melanoma Product Overview
  • Genetic Test - Prostate Cancer
  • Genetic Test - Prostate Cancer Product Overview
  • Genetic Test - Type 2 Diabetes
  • Genetic Test - Type 2 Diabetes Product Overview
  • Polygenic Risk Score Test - COVID-19
  • Polygenic Risk Score Test - COVID-19 Product Overview
Genetic Technologies Ltd - Key Competitors

Genetic Technologies Ltd - Key Employees
  • Genetic Technologies Ltd - Key Employee Biographies
Genetic Technologies Ltd - Locations and Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Recent Developments
  • Genetic Technologies Ltd, Recent Developments
  • Apr 17, 2020: COVID-19 testing capacity at Genetic Technologies accredited laboratory
  • Apr 01, 2020: Genetic Technologies announces market update on sales, early test results and launch of consumer initiated testing
  • Jan 31, 2020: Genetic Technologies: Quarterly report
  • Jan 07, 2020: 20 Medical centers across 8 US states set to offer breast cancer test
  • Dec 10, 2019: Genetype for Breast Cancer commissioned with sales to commence first quarter 2020
  • Dec 10, 2019: Genetype for Breast Cancer commissioned with sales to commence First Quarter 2020
  • Nov 05, 2019: Genetic Technologies Provides Shareholder Update on Recent Achievements and Upcoming Milestones
  • Sep 24, 2019: Genetic Technologies announces Director resignation
  • Sep 02, 2019: Genetic Technologies announces new board appointment
  • Jul 11, 2019: Genetic Technologies announces executive management team changes
Appendix
  • Methodology
  • About the Publisher
  • Contact Us
  • Disclaimer
List of Tables
  • Genetic Technologies Ltd Pipeline Products and Ongoing Clinical Trials Overview
  • Genetic Technologies Ltd Pipeline Products by Equipment Type
  • Genetic Technologies Ltd Pipeline Products by Indication
  • Genetic Technologies Ltd, Key Facts
  • Genetic Technologies Ltd, Major Products and Services
  • Genetic Technologies Ltd Number of Pipeline Products by Development Stage
  • Genetic Technologies Ltd Pipeline Products Summary by Development Stage
  • Genetic Test - Breast Cancer - Product Status
  • Genetic Test - Breast Cancer - Product Description
  • Genetic Test - Cardiovascular Disease - Product Status
  • Genetic Test - Cardiovascular Disease - Product Description
  • Genetic Test - Colorectal Cancer - Product Status
  • Genetic Test - Colorectal Cancer - Product Description
  • Genetic Test - Melanoma - Product Status
  • Genetic Test - Melanoma - Product Description
  • Genetic Test - Prostate Cancer - Product Status
  • Genetic Test - Prostate Cancer - Product Description
  • Genetic Test - Type 2 Diabetes - Product Status
  • Genetic Test - Type 2 Diabetes - Product Description
  • Polygenic Risk Score Test - COVID-19 - Product Status
  • Polygenic Risk Score Test - COVID-19 - Product Description
  • Genetic Technologies Ltd, Key Employees
  • Genetic Technologies Ltd, Key Employee Biographies
  • Genetic Technologies Ltd, Subsidiaries
  • Glossary
List of Figures
  • Genetic Technologies Ltd Pipeline Products by Equipment Type
  • Genetic Technologies Ltd Pipeline Products by Development Stage
Note: Product cover images may vary from those shown
3 of 3
  • Universal Biosensors Pty Ltd.
  • Sonic Healthcare Ltd
  • Portland Surgical Products Pty Ltd
  • Pharmaxis Ltd
  • AusBiotech Ltd
Note: Product cover images may vary from those shown
Adroll
adroll